476 / 1778
RT: 58% hazard reduction; absolute benefit for HIR 14%
➢
in patients who had lymphadenectomy and were pN0
HIR, no RT: 27%
HIR, RT: 13%
Keys et al, Gynecol Oncol 2004
GOG#99 - recurrence
|
|
476 / 1778
RT: 58% hazard reduction; absolute benefit for HIR 14%
➢
in patients who had lymphadenectomy and were pN0
HIR, no RT: 27%
HIR, RT: 13%
Keys et al, Gynecol Oncol 2004
GOG#99 - recurrence